| AE | Adverse event |
| AC | Adenylate cyclase |
| ADAM | A disintegrin and metalloproteinase |
| AML | Acute myelogenous leukemia |
| ARG | Arginase |
| ARHGAP10 | Rho GTPase-activating protein 10 |
| BC | Breast cancer |
| BCA | B-cell attracting chemokine |
| BRAK | Breast and kidney-expressed chemokine |
| CAF | Cancer-associated fibroblast |
| CAM | Cancer-associated mesothelial cells |
| cAMP | Cyclic adenosine monophosphate |
| CAR | Chimeric antigen receptor |
| CDK | Cyclin-dependent kinase |
| CHO | Chinese hamster ovary |
| CLL | Chronic lymphocytic leukemia |
| COX | Cyclooxygenase |
| CRC | Colorectal cancer |
| CRPC | Castration-resistant prostate cancer |
| DPPIV | Dipeptidyl peptidase IV |
| DC | Dendritic cell |
| DG | Diacylglycerol |
| DLBCL | Diffuse large B-cell leukemia |
| DMC | Dendritic cell- and monocyte-attracting chemokine-like protein |
| EGFR | Epidermal growth factor receptor |
| ELR | Glutamic acid-leucine-arginine |
| ENA | Epithelial neutrophil-activating peptide |
| EOC | Epithelial ovarian cancer |
| ER | Estrogen receptor |
| FGF | Fibroblast growth factor |
| FL | Follicular lymphoma |
| GAB2 | GRB2-associated binding protein 2 |
| GBM | Glioblastoma multiforme |
| GCP | Granulocyte chemotactic protein |
| GPI | Glycosylphosphatidylinositol |
| GRO | Growth-related oncogene |
| HB-EGF | Heparin-binding EGF-like growth factor |
| HCC | Hepatocellular carcinoma |
| HDI | Histone deacetylase inhibitor |
| HIF | Hypoxia-inducible factor |
| HNC | Head and neck cancer |
| HOSE | Human ovarian surface epithelium |
| HPMC | Human peritoneal mesothelial cell |
| HSC | Hematopoietic stem cell |
| HUVEC | Human umbilical vein endothelial cell |
| ICB | Immune checkpoint blockade |
| IFN | Interferon |
| IKK | Inhibitor of NF-κB kinase |
| IL | Interleukin |
| IP3 | Inositol 1,4,5-triphosphate |
| I-TAG | IFN-inducible T-cell alpha chemoattractant |
| MDS | Myelodysplastic syndrome |
| MDSC | Myeloid-derived suppressor cell |
| MIF | Macrophage migration inhibitory factor |
| MIG | Monokine induced by interferon-γ |
| MM | Multiple myeloma |
| MMP | Matrix metalloproteinase |
| MSS | Microsatellite stability |
| NAP | Neutrophil-activating peptide |
| Neu | Neutrophil |
| NF-κB | Nuclear factor kappa B |
| NSCLC | Non-small-cell lung cancer |
| OC | Ovarian cancer |
| OSCC | Oral squamous cell carcinoma |
| PAI-1 | Plasminogen activator inhibitor-1 |
| PC | Prostate cancer |
| PDAC | Pancreatic ductal adenocarcinoma |
| PF | Platelet factor |
| PI | Phosphatidylinositol |
| PI3K | Phosphoinositide 3-kinase |
| PIP2 | Phosphatidylinositol 4,5-bisphosphate |
| PKA/PKC | protein kinase A/C |
| PLC | Phospholipase C |
| pDC | Plasmacytoid dendrites |
| RCC | Renal cell carcinoma |
| SCCHN | Squamous cell carcinoma of head and neck |
| SDF-1 | Stromal cell-derived factor-1 |
| SR-POX | Scavenger receptor for phosphatidylserine and oxidized LDL |
| TAL | Tumor-associated lymphocyte |
| TAM | Tumor-associated macrophage |
| TAN | Tumor-associated neutrophil |
| TCSC | Tissue-committed stem cell |
| TIF | Tumor-induced factor |
| TIL | Tumor-infiltrating lymphocyte |
| TME | Tumor microenvironment |
| TNF | Tumor necrosis factor |
| VEGF | Vascular endothelial growth factor |